Live Breaking News & Updates on Akebia therapeutics

Stay informed with the latest breaking news from Akebia therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Akebia therapeutics and stay connected to the pulse of your community

AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease

AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Japan , France , United-states , Turkey , Switzerland , Sylvie-berrebi , Sandi-greenwood , Kyowa-kirin-korea-co , Akebia-therapeutics-inc , Panion-bf-biotech-inc , European-union

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Massachusetts , United-states , Mercedes-carrasco , Akebia-therapeutics-inc , Nasdaq , Akebia-therapeutics , Nasdaq-listing-rule ,

Akebia Therapeutics Surges on FDA Approval for Anemia Treatment

Akebia Therapeutics Inc. NASDAQ: AKBA is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia…

Nasdaq , Akebia-therapeutics-inc , Akebia-therapeutics , News , Ggregator , Reaking-news , Uration , Edia ,

Hematology Month in Review: March 2024

Our March 2024 month-in-review in hematology features updates to the anemia pipeline, the latest research in sickle cell disease, and the role of SGLT2 inhibition on hematologic outcomes.

United-states , Texas , Philadelphia , Pennsylvania , Japan , Memorial-hospital , Aleksandras-dain , Kieranf-docherty , Shih-chieh-shao , Keelung-chang-gung , National-inpatient-sample , Drug-administration

Baystreet.ca - Brace for Rate June Cuts: Inflation Moderated

Baystreet.ca - Brace for Rate June Cuts: Inflation Moderated
baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.

China , Chinese , Federal-reserve , Last-friday , Personal-consumption-expenditures , Akebia-therapeutics ,

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

Cambridge , Cambridgeshire , United-kingdom , Massachusetts , United-states , Akebia-therapeutics-inc , Nasdaq , Akebia-therapeutics , Nasdaq-listing-rule ,

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Cambridge , Cambridgeshire , United-kingdom , Mercedes-carrasco , Akebia-therapeutics-inc , Nasdaq , Akebia-therapeutics , Nasdaq-listing-rule ,

Baystreet.ca - Brace for Rate June Cuts: Inflation Moderated

Last Friday, the government posted the core Personal Consumption Expenditures index at 2.8% in February. This inflation measure excludes food and energy due to their volatility.

The weaker inflation rate supports the stock market’s view that the ...

China , Chinese , Federal-reserve , Last-friday , Personal-consumption-expenditures , Akebia-therapeutics ,

Akebia Recovers From Rejection to Win FDA Approval for Anemia Drug

Akebia Recovers From Rejection to Win FDA Approval for Anemia Drug
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Philadelphia , Pennsylvania , United-states , Japan , Americans , Japanese , Vifor-pharma , Johnson-opsynvi , Novartis , European-commission , Mirum-pharmaceuticals , Astrazeneca

Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday morning. Other analysts also recently issued research reports about the company. BTIG Research restated a buy rating and issued a $4.00 price target on shares of Akebia Therapeutics in […]

Johnp-butler , Renaissance-technologies , Blackrock-inc , Akebia-therapeutics-company-profile , Akebia-therapeutics-inc , Dimensional-fund-advisors , Millennium-management , Vanguard-group-inc , Akebia-therapeutics , Free-report , Therapeutics-stock-down